All
  • All
  • ELISA Kit
  • Protein
  • Antibody
  • Molecular Biology Product
  • Small Molecule
  • Peptide
All
  • All
  • ELISA Kit
  • Protein
  • Antibody
  • Molecular Biology Product
  • Small Molecule
  • Peptide

map Antibody

Datasheet
Code CSB-PA360042ZA01ENV
Size Enquire
Have Questions? Leave a Message or Start an on-line Chat

Product Details

Full Product Name
Rabbit anti-Escherichia coli (strain K12) map Polyclonal antibody
Uniprot No.
P0AE18
Target Names
map
Alternative Names
map antibody; b0168 antibody; JW0163Methionine aminopeptidase antibody; MAP antibody; MetAP antibody; EC 3.4.11.18 antibody; Peptidase M antibody
Raised in
Rabbit
Species Reactivity
Escherichia coli
Immunogen
A synthesized peptide derived from Escherichia coli map protein
Immunogen Species
Escherichia coli (strain K12)
Conjugate
Non-conjugated
Clonality
Polyclonal
Isotype
IgG
Purification Method
Antigen Affinity Purified
Concentration
It differs from different batches. Please contact us to confirm it.
Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Tested Applications
ELISA, Dot blot (guaranteed specific to the immunizing peptide)
Protocols
ELISA Protocol
Troubleshooting and FAQs
Antibody FAQs
Storage
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Value-added Deliverables
①. 100ug * KLH-conjugated peptide paired with 100ug * BSA-conjugated peptide (positive control);
②. 1ml*pre-immune serum (used as negative control) for free;
③. Rabbit polyclonal antibodies purified by Antigen Affinity;
Quality Guarantee
1. CUSABIO guarantees the antibody purity > 95% confirmed by SDS-PAGE.
2. CUSABIO guarantees the antibody titer > 1: 64,000 confirmed by ELISA.
3. CUSABIO guarantees to offer Peptide-specific Dot blot.
4. CUSABIO guarantees 100% risk-free: No qualified antibody, no charge.
Lead Time
Made-to-order (12-14 weeks)
Usage
For Research Use Only. Not for use in diagnostic or therapeutic procedures.

Related Products

map Antibodies

map Proteins

Customer Reviews and Q&A

■ Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Function
Removes the N-terminal methionine from nascent proteins. The N-terminal methionine is often cleaved when the second residue in the primary sequence is small and uncharged (Met-Ala-, Cys, Gly, Pro, Ser, Thr, or Val). Requires deformylation of the N(alpha)-formylated initiator methionine before it can be hydrolyzed.
Gene References into Functions
  1. These data suggest that map expression contributes to the maintenance of enteropathogenic Escherichia coli colonization. PMID: 25312947
  2. Methionine aminopeptidase associates with ribosomes via a charged loop crucial for nascent-chain processing & cell viability. It competes with peptide deformylase for binding sites at the ribosomal tunnel exit PMID: 23770820
  3. Data show that Europium ion (Eu(3+)) binds to methionine aminopeptidase and binding results in the activation of the enzyme. PMID: 22112844
  4. obtained a crystal structure for a complex of Escherichia coli methionine aminopeptidase with norleucine phosphonate, a transition-state analog, and only a single Mn(II) ion bound at the active site PMID: 16769889
Protein Families
Peptidase M24A family, Methionine aminopeptidase type 1 subfamily
Database Links
Promotions
Reward For Reviews
Free antibody trial
Contact Us

  Email: [email protected]
  Distributors Worldwide

Service

Phage Display Service

Antibody Service

Protein Service

Gene Synthesis Service

Oligo Synthesis Service

Related Articles
SWISS-PROT: When and How to Use It Protein Acetylation: An Important Post-translational Modification in Eukaryotic Cells Neuronal Markers and Neurodegenerative Diseases Melanoma, the Most Serious Type of Skin Cancer STAT3: a Key Transcriptional Regulator in Cancer Two Types of Macrophages: M1 and M2 Macrophages EGFR and Its Application in Cancer Therapy An Overview of Cell Death: Necrosis and Apoptosis The Overview of One Category of Important Cell Receptors: Receptor Tyrosine Kinases TNFRSF9: A Potent Immune-Stimulator in Cancer NRG1: an Intriguing Therapeutic Target in Diseases NKG2D, a Powerful Molecule Involved In CAR-T And Car-NK Cell Therapy DLL3: A New Molecular Target in Cancer Does LIF Only Play a Role in Leukaemia? DNA Damage and Repair Proteolysis Targeting Chimera (PROTAC): A "Revolutionary" Technology in Small Molecule Drug Discovery! CLDN6: A "New Favorite" in Targeted Cancer Therapy after CLDN 18.2! DDR1: a Novel Member of the RTKs Family, a Potential Target for Tumor Therapy! TPBG/5T4: the Oncofetal Protein, an Appealing Target for ADC or Vaccine Therapeutics in Tumors! With the High Potential in Cancer Immunotherapy, CD40 Is Triggering Attention CD14, A Membrane Receptor for Bacterial Lipopolysaccharides ERBB3/HER3: a New Target for Tumor Therapy, a Driver Gene of Multi-Tumors Cell Differentiation Determines the Fate of Cells Twice Halted in One Year! Is Akeso's CD73 Monoclonal Antibody in Jeopardy Again? Is PD-1's Golden Partner Still Worth It? CLDN4: A Potential Prognostic Indicator and Therapeutic Target in Tumors！ A Comprehensive Overview of Ovarian Cancer Protein Phosphorylation: The Dynamic Language of Cellular Regulation Tuberculosis--A Resurgent ULBP1: a Potent Member of NKG2D Ligands in CAR-T Therapy for Multiple Hematological and Solid Tumors! Homeobox Transcription Factor- NANOG How to Inquire and Utilize the Signal Pathway on KEGG Effects of FSHR on Fertility and Tumors DSG2: a Vital Member of Desmosomal Cadherin Family, an Exciting New Target for Cardiomyopathy, Adenovirus, and Tumors! ZG16B: A New Tumor Biomarker Offers Important Insights for Drug Development in Pancreatic Cancer! New Mechanism, NRP1 Enhances the Ability of SARS-CoV-2 Infection Oct4 -- The Gatekeeper of Pluripotency of Embryonic Stem Cells Interleukin 4 receptor (IL-4R/IL-4Ra): a Multifunctional Target of Cytokines, Suggesting Diverse Potential in Asthma, Rhinitis, Viral, and Tumor Research! Bladder Cancer: Insights into Molecular Biology,Signaling Pathways, and Biomarkers IL-6-Do You Really Know That? Normal Growth Hormone Levels But Still Can't Grow Tall? 2026 Latest Research: Perhaps the GH1 Gene Holds Hidden Secrets CEACAM5: A Promising Member of CEACAM Family, A Potential Target for ADC Drug Research! LPS/TLR4 Signal Transduction Pathway Toll-like Receptors--The Eye of Innate Immunity A Comprehensive Exploration into Amyotrophic Lateral Sclerosis Focus on Emerging Therapeutic Targets BCMA What Are Immune Checkpoint Pathways? CD20 Monoclonal Antibodies Drugs: There is an Explosion of New mAbs Against CD20! VSIG4: a Prominent B7 Family Costimulatory Molecule or Complement Receptor in Cancers and Inflammatory Diseases! SLC39A6/ZIP6: a Key Member of Zinc Transporters, a Novel Targeting Antigen of ADC! What You Have To Know about Lung Cancer TMEFF2: a Tumor-Specific Methylated Biomarker, a Novel Target in Multiple Cancers Protein Kinases Overview: Definition, Types, Function, Activation Mechanism, etc. The Overview of Hippo Signaling Pathway Exploring Neurodegeneration: A Comprehensive Guide for Researchers Tools You Need For Fundamental Research How do Th1 and Th2 Cells Differentiate? A groundbreaking breakthrough! Domestic "sandwich" regimen boosts 2-year survival rate to 97% in B-ALL patients, as the CD22 target achieves another success. What Powerful Model Organism Databases Protein Tyrosine Kinases: Anti-tumor Targets to be Explored Urgently TCGA Database- A Good Partner of Researchers GIPR: the Crucial Regulator of Glucose and Lipid Metabolism in Diabetes and Obesity! How Does Histone Modification Affect Gene Expression? How to Measure Histone Modification? Histone modification and Cancer About Thyroid Tumor: Essential Information for Researchers What A Paradoxical TNF Signaling Pathway-Based on Different Receptors What Essential Biological Knowledge is Needed for Hepatocellular Carcinoma Research? What Are the Effects of Abnormalities in the ALK Gene These Tumor Databases You Have To Know Introduction of Hepatocellular Carcinoma Related Signaling Pathways Mesothelin: A Rising Star of Cancer Immunotherapy CD70 (CD27L/TNFSF7): a TNF Receptor Member, a “Star” Target for Clinical Research in Systemic Lupus Erythematosus (SLE), Arthritis, and Tumors! Diabetes: What You Need to Know Before Starting Research? ACE2, The Hottest Target of SARS-CoV-2 Invasion Epitope Tags Overview Tetraspanin CD81: a Key Receptor for Hepatitis C Virus (HCV), an Established Exosome Marker, a Promising Target for Antiviral or Antitumor Research! Does TNF Superfamily Inhibit Cancer or Promote Its Development? TROP2, An Important Target for Cancer Research GLP-1R: An Energy Metabolism Regulator of GPCR Family, an Effective Drug Target for Type 2 Diabetes Therapy! TM4SF1: a Member of the Transmembrane-4-Superfamily (L6), a New Vascular Therapeutic Target? LY6G6D (LY6-G): A New Member of Lymphocyte Antigen-6 Family Holds Big Opportunities in Bispecific Antibody for CRC Treatment! Applications of recombinant proteins The Overview of Chemokine Protein Tags: A Comprehensive Overview Myosin Regulatory Light Chains (MYL12A and MYL12B): the New Functional Ligands for CD69, Potential Targets for Cardiac Disease or Tumors Research? The Overview of Colony Stimulating Factors EphA3-A Regulator of Cell Adhesion and Migration Cadherin-17 (CDH17): A Viable Target in Bispecific Antibodies or CAR-T Therapy to Fight Many Gastrointestinal Cancers! The Memory thief - Alzheimer's disease The Overview of Growth Factor Tumor Necrosis Factor (TNF) Tumor markers The Overview of Interleukin The Overview of Organelles The Overview of Autophagy Phage Display: From Antibody Discovery to Therapeutic Breakthroughs CDCP1: A Key Mediator for Cell Signaling in Cancers, an Emerging Target for Anti-Tumor Drugs! The overview of Wnt signaling pathway The overview of TGF-β signaling pathway PI3K-Akt Signaling Pathway and Cancer The "Plaque Cleaner" in Blood Vessels Has Arrived! CD25+ Regulatory T Cells Transform into CAR-Tregs with Amazing Results The Review of Post-translational Modifications CXCR4: An Attractive Target of GPCR family Brings Promising New Drugs for Cancer Therapy！ PROM1 (CD133): A New Cell Surface Marker of Cancer Stem Cells (CSCs), A More Significant Target for Immunotherapy! ENPP3 (CD203c): An Extracellular Enzyme, a Regulator for Nucleotide and Energy, an Indicator for Allergies, an Effective Target for RCC Therapy! SEMA4D/CD100: As an Important Immunoregulator to Improve Immunotherapy SSTR2: A Prominent Target in SSTR Family, Offers a More Precise Therapy in Neuroendocrine Tumors (NET) Oncostatin M (OSM): A Member of IL-6 Cytokine Family, An Underestimated Player in Future Targeted Therapies? CNR1 (CB1): A Crucial Receptor of Endocannabinoid System Offers Potential Treatments for Tumors and Glycolipid Metabolism Disorders! DSG3: An Emerging Tumor-Associated Adhesion Factor, a Specific Marker for the Clinical Diagnosis of Pemphigus Vulgaris (PV)! Targeting LRRC15: From tumor microenvironment regulation to fibrotic/infectious disease therapy Dipeptidase 3 (DPEP3): an Emerging Member of the DPEP Family, a Potential Therapeutic Target in Male Fertility or Tumor Research! Exploring Protein-Protein Interactions: A Comprehensive Guide to Understanding and Utilizing It IL-6: an Important Participant in the Inflammatory Cascade, One of the Most Functional Cytokines in Various Diseases Research! CT83/KK-LC-1: a Promising Therapeutic Target of CTAs Family, Currently in Clinical Research for Breast, Lung, Gastric Cancers, and Beyond! T Cell Activation - The Switch for T Cell Executive Function Verified vs. Unverified Recombinant Proteins: Making the Right Choice for Your Research What Bacterial Antigens Are Used in Vaccines? ACVR2A and ACVR2B as Key Targets for Muscle Growth, Weight Loss, PHA in Drug Research！ TNFSF15/TL1A: The Rise of the Next Billion-Dollar Target as Pharma Giants Stake Their Claims CD79A and CD79B: Key Targets in B Cell Signaling Pathways and Therapeutic Potential CSF2/GM-CSF: A Key Molecule in Immune Regulation and Disease Treatment TNFSF18: Unlocking New Frontiers in Cancer Immunotherapy How AI is Reshaping Biological Research? A Comprehensive Guide to Tools and Practical Strategies IL-6: A Central Factor in Cytokine Storms and a Health Alert for Infections and Diseases TNFRSF13C (BAFF-R): A Key Target for Immune Regulation and Disease Treatment PVR (CD155): A Key Factor in Tumor Immune Evasion and a Novel Therapeutic Target How the Tumor Microenvironment Fuels Cancer's Deadly Evolution MSTN: A Key Target for Targeted Therapy in Muscle Diseases​ Decoding Recombinant Protein Expression: Strategic Solutions & Practical Insights CEACAM1: An Emerging Multifunctional Target for Cancer-Immune Modulation EDNRA: A Key Target for Disease-Associated Angioplasty, Tumor Invasion, and Metabolic Regulation IL2's 'Double-Edged Sword' Strikes Again: PD1/IL2/VEGF Trispecific Antibodies Emerge at AACR 2026, Nektar's Autoimmune Data Sparks Heated Discussion PTH1R: Key Therapeutic Target in Bone & Metabolic Health Colony Stimulating Factor 1 (CSF1): Its Key Role in Diseases and New Progress in Targeted Therapy B7-H6: A Key Ligand of NK Cell Immune Checkpoints Reshaping the Landscape of Tumor Immunotherapy MICB: a key molecule that bridges cellular stress and immune responses MICA: key regulatory molecule for tumor immune surveillance and its therapeutic target potential TSLP: A Key Target in Allergic and Inflammatory Diseases Targeting the "Hidden Target" ROR1: A Breakthrough for Broad-Spectrum Cancer Therapy? Nicotinic Acetylcholine Receptor α1 Subunit (CHRNA1): Structure, Functional Mechanisms, and Disease-Related Research Progress FLT1 (VEGFR-1): A Bidirectional Regulator of Angiogenesis and an Emerging Therapeutic Target Metabolic Hub, Reprogramming Disease: SLC3A2 – From Amino Acid Transport Mechanism to Emerging Therapeutic Target SIGLEC15: An Emerging Immune Checkpoint Target in Tumor Immunotherapy In-depth Dialogue on the "Core Triangle" of Inflammation: How IL-6, IL-1β, and TNF-α Interact to Drive Disease Progression? Targeting EphA2: An Emerging Focus in Combating Tumor Drug Resistance and Metastasis IL1RAP: Background, Research Mechanisms, Signaling Pathways, Related Diseases, and Latest Advances in Drug Development PDGFRA: A Hub in Cellular Signaling and a Therapeutic Target The Multifaceted World of ADAM9: Beyond Proteolytic Function CRLF2 (TSLPR): A Key Target Linking Type 2 Inflammation to Hematologic Malignancies FCGR3A: A Key Receptor for Immune Regulation ACVR1C/ALK7: An Emerging Target in Metabolic Diseases and Cancer Therapy ANGPTL3: From Mechanisms to Clinics, Exploring a Novel Therapeutic Target for Cardiometabolic Diseases Client Literature Review IF=52.7: Targeting SKAP2 Restores Sperm Motility and Morphology by Regulating Mitochondrial Organization and Cytoskeletal Remodeling Emerging Therapeutic Target ANGPTL4: A Key Molecule Linking Metabolism, Inflammation, and Tissue Remodeling BDNF/Brain-Derived Neurotrophic Factor: From Neuroplasticity Regulation to Core Target for Neuropsychiatric Disease Therapy CDH1/E-cadherin: Research Progress on a Core Target from Adhesion Regulation to Tumor Therapy Overview of CCR4 Target: Core Roles in Physiological Functions and Pathological Regulation CD28: Molecular Mechanism and Therapeutic Progress of the Core Co-Stimulatory Receptor in T Cells CCN2 (CTGF) Target: Core Molecule of Fibrosis and Tumor Stroma Regulation | Disease Treatment Research Progress BTN3A1 (CD277) Target: γδ T Cell Immune Recognition Mechanism and Cancer Immunotherapy Research Progress CD33 (Siglec-3) Signaling Pathways and Disease Mechanisms: Roles in Acute Myeloid Leukemia, Alzheimer’s Disease and Immune Regulation CD19: Molecular Mechanisms, Disease Associations and Progress in Targeted Therapy Fibroblast Growth Factor 2 (FGF2): Molecular Mechanisms, Signaling Pathways, Disease Associations and Therapeutic Advances The CD200/CD200R Signaling Axis: A Critical “Brake” in Maintaining Immune Homeostasis Beyond PD-1/CTLA-4! The Emerging Immune Checkpoint CD160 is Transforming the Landscape of Tumor Immunotherapy Antibody FAQs What Is an Antibody? How to Choose an Antibody for Scientific Research? The difference between primary antibody and secondary antibod The Meaning of Irregular Antibody Screening Tag Antibodies, Your Good Partner in Protein Research How to Choose the Loading Control Antibodies?
CUSABIO guaranteed quality
icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of email
Email
[email protected]
icon of address
Address
7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2026 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1
Privacy Policy